Fig. 2From: MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2-positive breast carcinoma patients treated with neoadjuvant trastuzumab-based therapyROC curves for different parameters measuring MET gene copy number relative to chromosome 7 copy number. Parameters plotted include: MET/CEN7 gain or loss (solid line with solid triangles), MET/CEN7 gain (dotted line with solid diamonds), MET/CEN7 loss (short dashed line with open squares), MET/CEN7 (high ratios associated with pCR; long dashed line with solid circles), and MET/CEN7 (low ratios associated with pCR; alternating dashed and dotted line with open triangles)Back to article page